Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1260 results for "fda"

U.S. FDA wants more data on sunscreen additives before approval

FDA clears new indication for Lilly's Cyramza

The FDA approves a fourth indication for Eli Lilly's (NYSE:LLY) Cyramza (ramucirumab), for the treatment, in combination with FOLFIRI chemotherapy, of patients with metastatic colorectal cancer with disease progression on or after therapy with ... Seeking Alpha, 17 hours ago
FDA Approves Ramucirumab for Metastatic Colorectal Cancer Gastroenterology & Endoscopy News, 6 hours ago

6,220 images for fda, 1 hour ago
MedIndia, 1 day ago, 21 hours ago
Med India, 2 days ago
Med India, 2 days ago
Med India, 3 days ago
Monthly Prescribing Reference, 2 days ago
MassDevice, 2 days ago, 1 day ago
MedIndia, 3 days ago
India Infoline

FDA raids stalls selling ‘unhygienic’ food

Food and Drugs Administration (FDA) is conducting checks at all the interstate bus stands in the state to crack a whip against the alleged sale of unhygienic food at stalls during the night time
 Times of India17 hours ago Maharashtra FDA plans massive crackdown on online sale of prescription drugs  PharmaBiz2 days ago FDA cracks down on portals for selling schedule X drugs  Times of India4 days ago Snapdeal raided by Maharashtra FDA for selling prescription drugs online  Zee News4 days ago

AbbVie Reveals FDA Priority Review For Investigational Therapy In Hepatitis C

AbbVie (ABBV: Quote) Friday said the U.S. Food and Drug Administration has accepted its New Drug Application and granted priority review for the company's, all-oral, interferon-free, two direct-acting antiviral treatment of ombitasvir, paritaprevir, ...
 RTTNews.com1 day ago AbbVie's all-oral, interferon-free therapy for Hepatitis C receives priority review from FDA  FirstWord Pharma21 hours ago ABBVIE : Hepatitis C Drug Granted Priority FDA Review  4 Traders1 day ago Boehringer's BLA for idarucizumab gets FDA priority review  Pharmaceutical Business Review1 day ago

GW Pharmaceuticals At All-Time High Levels on Cannabidiol FDA-Status, Amazon Soars on Sales Growth

GW Pharmaceuticals PLC ( GWPH ) Shares of GW Pharmaceuticals PLC ( GWPH )touched an all-time high of $122.82 during Friday's trading session as the company said that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation ...
 Guru Focus16 hours ago CanTx's chemotherapy drug candidate, Cantrixil receives orphan drug status from US FDA for ovarian cancer  PharmaBiz2 days ago GW Pharmaceuticals has announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Cannabidiol (CBD) for use in treating newborn children with neonatal hypoxic-ischemic encephalopathy (NHIE). NHIE is acute or s  Money Week1 day ago GW Pharma Gets Big Analyst Upgrade Into Cannabinoid FDA Orphan Drug Designation  24/7 Wall St1 day ago

Nipro Diagnostics Wins FDA Approval for True Metrix Air

Nipro Diagnostics True Metrix Air self-monitoring blood glucose system, capable of wirelessly delivering data to a smartphone, has received FDA 510(k) clearance, the Fort Lauderdale, Fla., devicemaker announced Friday. The device's test strips ...
 FDA News14 hours ago Nipro Diagnostics Announces FDA Clearance of TRUE METRIX AIR  Industrial Info Financials1 day ago Siemens gains add-on breast tomosynthesis FDA approval, as startup files first PMA for computer-aided detection  FierceMedicalDevices1 day ago FDA Approves Breast Tomosynthesis Option for Siemens Mammography Platform  SearchBug2 days ago

Portable Ultrasound Saves Lives in Remote Rural Central America FDA Clearance for Novel 3-D Interactive Virtual Reality System New Wireless Flat Panel Detector to Meet Growing Latin American Imaging Needs Events more events 27 Apr 2015 - 01 May 2015 SPR 2

A report by Kalorama Information (New York, NY, USA) analyzing the global Computed Tomography (CT) market has been published. The report surveyed the CT market outlook until 2018, and the drivers behind the changes. The report investigated CT market ...
 MedImaging.net9 hours ago

Quotables: FDA weighs testimony on homeopathic remedies

iStock Homeopathic medicinemay get closer scrutiny from the U.S. Food and Drug Administration (FDA) after a two-day public hearing , which wrapped this week.Experts on both sides of the argument testified, with some praising ...
 UnitedHealthcare13 hours ago Homeopathy drugs under FDA scanner  Deccan Herald1 day ago

What Is BMPEA? Weight Loss Supplement Ingredient Similar To Amphetamine Comes Under FDA Scrutiny

Five makers of weight loss and exercise supplements have been told to stop selling products containing a certain compound whose safety has been called into question. The Food and Drug Administration issued the warning Thursday, alleging that the ...
 Austin American Statesman16 hours ago FDA Warns Weight Loss, Workout Supplement Sellers Listing BMPEA; Amphetamine Relative Not Natural  Forbes.com1 day ago FDA Issues Warning On Weight Loss SupplementsContaining Dangerous 'Super Caffeine  Yahoo! News20 hours ago Contentious Weight Loss Drug Not Natural Warns FDA  EMax Health23 hours ago

FDA's Finalized Deeming Regulation Will Not Be End of Rulemaking

LAS VEGAS — One year ago, the Food and Drug Administration (FDA) released its proposed deeming regulation that would give it the authority over electronic cigarettes, cigars, pipe tobacco and certain dissolvable products that are not smokeless ...
 Convenience Store News16 hours ago Food Marketing Institute Emphasizes Food Safety Strategies at FDA Public Hearing  Food Marketing Institute21 hours ago FDA Proposes to Amend Food Facility Registration Regulation  Noodls1 day ago Top FDA, FSIS Food Safety Officials Weigh in on Key Issues  Food Safety Magazine1 day ago

FDA News Roundup: AstraZeneca, Pfizer, AbbVie, Actavis, And More

By Anna Rose Welch , associate editor What FDA decisions did you miss this week? Orphan Drug Designations AstraZeneca's MEK inhibitor selumetinib was named an orphan drug for uveal melanoma. The drug, which inhibits the MEK pathway and ...
 Pharmaceutical Online12 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - fda
Get updated on latest news & your favorite topics right in your inbox!
More     Less